Concepedia

Tanja Busk Bidstrup

TB

Statistics

Publications

4

Citations

352

H-Index

4

Active since

2003

Affiliations

University of Southern Denmark(Current)

Odense University Hospital

Novo Nordisk (Denmark)

Tanja Busk Bidstrup is an author at University of Southern Denmark specializing in pharmacology, pharmacokinetics, and pharmacy.

Publications per year

2003–2006

4

Publications

4

CYP2C8 and CYP3A4 are the principal enzymes involved in the human <i>in vitro</i> biotransformation of the insulin secretagogue repaglinide

Tanja Busk Bidstrup, Inga Bjørnsdottir, Ulla G. Sidelmann et al. · British Journal of Clinical Pharmacology · 2003 · 203 citations · Full text

, , +17

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide

Tanja Busk Bidstrup, Nicolaj M. Stilling, Per Damkier et al. · European Journal of Clinical Pharmacology · 2004 · 83 citations

, , +6

The impact of<i>CYP2C8</i>polymorphism and grapefruit juice on the pharmacokinetics of repaglinide

Tanja Busk Bidstrup, Per Damkier, Marianne Ekblom et al. · British Journal of Clinical Pharmacology · 2005 · 43 citations · Full text

, , +6

The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers

Lene Noehr‐Jensen, Per Damkier, Tanja Busk Bidstrup et al. · European Journal of Clinical Pharmacology · 2006 · 23 citations

, , +9

1–4 of 4